Low Intensity Shock-wave Therapy (Li-ESWT) in Penile Rehabilitation After Radical Prostatectomy

NCT ID: NCT03862599

Last Updated: 2023-03-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-06-01

Study Completion Date

2025-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Erectile dysfunction (ED) is reported in up to 85% of men who have undergone a radical prostatectomy for prostate cancer. A few small studies have recently shown that low-intensity shockwave therapy may improve sexual performance in men with ED. However, the optimal dosage and length of treatment is yet to be determined. The investigators propose a randomised trial evaluating the efficacy and safety of low-intensity shockwave therapy in men with ED following prostatectomy surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Erectile dysfunction (ED) is reported in up to 85% of men who have undergone a radical prostatectomy for prostate cancer. At present, this debilitating consequence of surgery is managed in a step-wise approach including oral medication, injections and in severe cases, insertion of a penile prosthesis. A few small studies have shown that low-intensity shockwave therapy may improve sexual performance in men with ED. However, the optimal dosage and length of treatment is yet to be determined. The investigators propose a randomised trial evaluating the efficacy and safety of low-intensity shockwave therapy in men with ED following prostatectomy surgery. Low-intensity shockwave therapy would be a non-invasive treatment to preserve and improve patient's sexual function.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Erectile Dysfunction Following Radical Prostatectomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomised controlled trial
Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors
Masking of probe applicator at device manufacturer before ESWT use

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard care + sham ESWT

Cialis and Vacuum pump + sham Extra-corporeal shockwave therapy (ESWT)

Group Type SHAM_COMPARATOR

Extra-corporeal shockwave therapy (ESWT)

Intervention Type DEVICE

low-intensity extra-corporeal shockwave therapy

Standard care

Intervention Type OTHER

Cialis and vacuum pump

Standard care + active ESWT

Cialis and Vacuum pump + active Extra-corporeal shockwave therapy (ESWT)

Group Type ACTIVE_COMPARATOR

Extra-corporeal shockwave therapy (ESWT)

Intervention Type DEVICE

low-intensity extra-corporeal shockwave therapy

Standard care

Intervention Type OTHER

Cialis and vacuum pump

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Extra-corporeal shockwave therapy (ESWT)

low-intensity extra-corporeal shockwave therapy

Intervention Type DEVICE

Standard care

Cialis and vacuum pump

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 40 - 65
* Diagnosed with low/intermediate-risk prostate cancer:
* PSA \< 20 ng/ml
* Gleason score \< 8
* PCa stage =\< T2b
* Baseline IIEF-ED 17-30 without erectogenic aids
* No pre-operative urinary incontinence (no usage of urinary pads)
* Sexually active
* Able to understand and complete patient questionnaires
* Consent to participate

Exclusion Criteria

* Anatomical abnormalities in the genitalia or pelvic region
* Post-RP complications that could impact safety or effectiveness of ESWT (eg. hematoma, fistula, unresolved anastomotic leak)
* Incomplete tumor removal (positive surgical margin)
* Tumor upstaging beyond T2b
* Nerve sparing score \> 5
* Previous or scheduled treatment with pelvic radiotherapy and/or androgen deprivation therapy
* Untreated hypogonadism (serum total testosterone \< 300 mg/dL)
* Anti-coagulant medication, except acetylsalicyclic acid up to 100mg daily
* Any other condition that would prevent the patient from completing the study, as judged by the principle investigator
Minimum Eligible Age

40 Years

Maximum Eligible Age

65 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Guy's and St Thomas' NHS Foundation Trust

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tet Yap

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tet Yap, FRCS (Urol)

Role: PRINCIPAL_INVESTIGATOR

Guy's and St Thomas' NHS Foundation Trust

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Guy's and St Thomas' NHS Trust

London, , United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Tet Yap, FRCS (Urol)

Role: CONTACT

07748182772

Findlay MacAskill, MRCS

Role: CONTACT

07748182772

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Findlay MacAskill, MRCS

Role: primary

07926073398

References

Explore related publications, articles, or registry entries linked to this study.

Kalyvianakis D, Memmos E, Mykoniatis I, Kapoteli P, Memmos D, Hatzichristou D. Low-Intensity Shockwave Therapy for Erectile Dysfunction: A Randomized Clinical Trial Comparing 2 Treatment Protocols and the Impact of Repeating Treatment. J Sex Med. 2018 Mar;15(3):334-345. doi: 10.1016/j.jsxm.2018.01.003. Epub 2018 Feb 1.

Reference Type BACKGROUND
PMID: 29396020 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

250004

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.